Tatsuo Nakajima

Title: Innovations of Tatsuo Nakajima

Introduction

Tatsuo Nakajima is a notable inventor based in Gunma-ken, Japan. He has made significant contributions to the field of pharmaceuticals, holding a total of 3 patents. His work focuses on developing innovative solutions for various medical conditions.

Latest Patents

One of Nakajima's latest patents is for N-{2-chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-N'-(5-methyl-3-isoxazolyl)urea salt in crystalline form. This invention provides a crystal of a pharmaceutically acceptable salt that is useful in treating diseases such as tumors, diabetic retinopathy, chronic rheumatism, psoriasis, atherosclerosis, Kaposi's sarcoma, and exudation type age-related maculopathy. The characteristics of this crystal make it suitable for applications in oral pharmaceutical preparations. Another significant patent is for a process for producing quinolone derivatives. This process involves allowing an o-aminoacetophenone derivative to react with formic acid in an aprotic solvent, followed by the addition of a protic solvent. This method offers a simple approach for producing 4-quinolone derivatives, making it applicable for large-scale commercial production.

Career Highlights

Tatsuo Nakajima is associated with Kirin Beer Kabushiki Kaisha, where he applies his expertise in pharmaceutical innovations. His work has contributed to advancements in the field, particularly in the development of therapeutic agents.

Collaborations

Nakajima has collaborated with notable coworkers, including Hideki Okawara and Nobuyuki Ogawa. Their combined efforts have furthered research and development in their respective fields.

Conclusion

Tatsuo Nakajima's contributions to pharmaceutical innovations highlight his role as a significant inventor in Japan. His patents reflect a commitment to improving medical treatments and advancing scientific knowledge.